CD27 and hepatocellular carcinoma: These lymphocytes showed surface markers that are typically found on antigen-presenting cells and demonstrated the ability to kill HCC tumor cells [56], but our findings indicate that an increase in IgD-CD27-AC elevates the risk of HCC.